Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling
- 227 Downloads
The aim of this study is to investigate the effects of inhibiting Aurora-B on osteosarcoma (OS) cell malignant phenotype, phosphorylation of valosin-containing protein (VCP), and the activity of NF-κB signaling in vitro. The expressions of Aurora-B and p-VCP proteins were detected by immunohistochemistry in 24 OS tissues, and the relationship between Aurora-B and p-VCP was investigated. The results showed that there was a positive correlation between Aurora-B and p-VCP proteins. The expression of Aurora-B in human OS cell lines U2-OS and HOS cells was inhibited by specific short hairpin RNA (shRNA) lentivirus (AURKB-shRNA lentivirus, Lv-shAURKB) which targeted Aurora-B. The results showed that the phosphorylation of VCP, the activity of NF-κB signaling pathway and the malignant phenotype of OS cells were all suppressed by knockdown of Aurora-B. It indicated that the inhibition of Aurora-B alters OS cells malignant phenotype by downregulating phosphorylation of VCP and activating of the NF-κB signaling pathway in vitro.
KeywordsOsteosarcoma Aurora-B Metastasis Valosin-containing protein (VCP) NF-κB signaling pathway
The present study was supported by grants from the National Natural Science Foundation of China (no. 81260400), the Natural Science Foundation of Jiangxi Province (no. 20114BAB205093 and 20142BAB205056), and Jiangxi Province Education Department of Science and Technology (no. GJJ12097).
Conflicts of interest
- 4.Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, et al. Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. J Biol Chem. 2012;287(35):29887–98. doi: 10.1074/jbc.M112.371682.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Tsuno T, Natsume A, Katsumata S, Mizuno M, Fujita M, Osawa H, et al. Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells. J Neurooncol. 2007;83(3):249–58. doi: 10.1007/s11060-007-9335-1.CrossRefPubMedGoogle Scholar
- 7.Hetland TE, Nymoen DA, Holth A, Brusegard K, Florenes VA, Kaern J, et al. Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Hum Pathol. 2013;44(5):777–85. doi: 10.1016/j.humpath.2012.08.002.CrossRefPubMedGoogle Scholar
- 19.Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, et al. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases. J Virol. 2013;87(22):12121–38. doi: 10.1128/JVI. 02379-13.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Marampon F, Gravina GL, Popov VM, Scarsella L, Festuccia C, La Verghetta ME, et al. Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines. Int J Oncol. 2014;44(1):285–94. doi: 10.3892/ijo.2013.2167.PubMedGoogle Scholar
- 24.Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, et al. NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res. 2003;415 Suppl:S75–85. doi: 10.1097/01.blo.0000093048.96273.aa.